Sif Ormarsdóttir

735 total citations
10 papers, 257 citations indexed

About

Sif Ormarsdóttir is a scholar working on Epidemiology, Hepatology and Orthopedics and Sports Medicine. According to data from OpenAlex, Sif Ormarsdóttir has authored 10 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Hepatology and 3 papers in Orthopedics and Sports Medicine. Recurrent topics in Sif Ormarsdóttir's work include Liver Disease Diagnosis and Treatment (7 papers), Liver Diseases and Immunity (4 papers) and Bone health and osteoporosis research (3 papers). Sif Ormarsdóttir is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver Diseases and Immunity (4 papers) and Bone health and osteoporosis research (3 papers). Sif Ormarsdóttir collaborates with scholars based in Sweden, Germany and United Kingdom. Sif Ormarsdóttir's co-authors include Hans Mallmin, Lars Lööf, Östen Ljunggren, H. Brahm, Sigurður Ólafsson, Magnús Jóhannsson, Leonard B. Seeff, Paul B. Watkins, Michael Merz and Arie Regev and has published in prestigious journals such as Journal of Hepatology, Annals of the Rheumatic Diseases and Journal of Internal Medicine.

In The Last Decade

Sif Ormarsdóttir

9 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sif Ormarsdóttir Sweden	8	108	72	65	63	43	10	257
Juan Ramón Hernández Hernández Spain	7	32 0.3×	56 0.8×	5 0.1×	19 0.3×	29 0.7×	41	311
Esther Ruiz-Lucea Spain	6	24 0.2×	24 0.3×	14 0.2×	31 0.5×	12 0.3×	7	338
Samir R. Shah India	7	148 1.4×	134 1.9×	6 0.1×	6 0.1×	14 0.3×	14	234
Takao Miwa Japan	11	214 2.0×	194 2.7×	5 0.1×	9 0.1×	34 0.8×	71	395
Hiroshi Ooyama Japan	9	37 0.3×	17 0.2×	7 0.1×	27 0.4×	24 0.6×	18	278
Lidan Ma China	9	71 0.7×	22 0.3×	9 0.1×	32 0.5×	4 0.1×	16	269
H. H. Dahm Germany	5	142 1.3×	156 2.2×	4 0.1×	37 0.6×	79 1.8×	7	249
Masaaki KANAYAMA Japan	11	68 0.6×	38 0.5×	3 0.0×	22 0.3×	21 0.5×	41	321
Chantal de Galocsy Belgium	9	194 1.8×	168 2.3×	2 0.0×	45 0.7×	11 0.3×	20	324
Fahri Güneş Türkiye	11	67 0.6×	14 0.2×	5 0.1×	11 0.2×	38 0.9×	30	351

Countries citing papers authored by Sif Ormarsdóttir

Since Specialization

Citations

This map shows the geographic impact of Sif Ormarsdóttir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sif Ormarsdóttir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sif Ormarsdóttir more than expected).

Fields of papers citing papers by Sif Ormarsdóttir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sif Ormarsdóttir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sif Ormarsdóttir. The network helps show where Sif Ormarsdóttir may publish in the future.

Co-authorship network of co-authors of Sif Ormarsdóttir

This figure shows the co-authorship network connecting the top 25 collaborators of Sif Ormarsdóttir. A scholar is included among the top collaborators of Sif Ormarsdóttir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sif Ormarsdóttir. Sif Ormarsdóttir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Regev, Arie, Leonard B. Seeff, Michael Merz, et al.. (2014). Causality Assessment for Suspected DILI During Clinical Phases of Drug Development. Drug Safety. 37(S1). 47–56. 48 indexed citations

Miossec, Pierre, C L Verweij, Lars Klareskog, et al.. (2011). Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies. Annals of the Rheumatic Diseases. 70(10). 1713–1718. 26 indexed citations

Jóhannsson, Magnús, Sif Ormarsdóttir, & Sigurður Ólafsson. (2010). Lifrarskaði tengdur notkun á Herbalife. Læknablaðið. 2010(3). 167–172. 24 indexed citations

Ormarsdóttir, Sif, Hans Mallmin, Tord Naessén, et al.. (2004). An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis. Journal of Internal Medicine. 256(1). 63–69. 37 indexed citations

Ormarsdóttir, Sif, Östen Ljunggren, Hans Mallmin, et al.. (2002). Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well‐preserved liver function. Journal of Internal Medicine. 252(6). 537–541. 7 indexed citations

Ormarsdóttir, Sif, Östen Ljunggren, Hans Mallmin, Karl Michaëlsson, & Lars Lööf. (2002). Increased rate of bone loss at the femoral neck in patients with chronic liver disease. European Journal of Gastroenterology & Hepatology. 14(1). 43–48. 25 indexed citations

Ormarsdóttir, Sif, Östen Ljunggren, Hans Mallmin, et al.. (2001). Circulating levels of insulin‐like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density. Liver International. 21(2). 123–128. 23 indexed citations

Ormarsdóttir, Sif, Östen Ljunggren, Hans Mallmin, et al.. (2001). Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver disease. Journal of Gastroenterology and Hepatology. 16(12). 1409–1414. 20 indexed citations

Ormarsdóttir, Sif. (2001). Osteoporosis in Chronic Liver Disease. KTH Publication Database DiVA (KTH Royal Institute of Technology).

10.

Ormarsdóttir, Sif, Östen Ljunggren, Hans Mallmin, H. Brahm, & Lars Lööf. (1999). Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease. Journal of Hepatology. 31(1). 84–90. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact